Skip to content

Moderna MRNA Grant revenue — Award amount

Discontinued — last reported Q1 '25

Similar metrics at other companies

FormFactor logo
FORMDeferred grant
$18M0.0%
JFrog Ltd. logo
FROGGrants — Maximum Additional Payments As A Grant Recipient1
$6M
Aaon logo
AAONGrant proceeds received
$1.65M
Universal Health Services logo
UHSIncrease Decrease In Deferred Grant Revenue
$0
Huntington Ingalls Industries logo
HIIGrant proceeds for capital expenditures
$3M
AeroVironment logo
AVAVIncome recognized in respect of BARDA
$19.62M-4.4%

Other financials

Income statement

See full
Revenue$389.0M+260%
Gross profit-$566.0M-3,244%
Operating income-$1.4B-32.2%
Net income-$1.3B-38.3%
EPS (diluted)-$3.40-34.9%

Balance sheet

See full
Cash & equivalents$1.9B+17.4%
Total debt$1.3B+71.9%
Total equity$7.4B-26.4%
Total assets$11.5B-9.6%

Cash flow

See full
Operating cash flow-$630.0M+39.2%
CapEx$62.0M-47.0%
Free cash flow-$692.0M+40.0%

Valuation

See full
Market cap$25.38B+83.8%
Enterprise value$24.8B+93.6%
P/S11.4×+7.1×

Profitability

See full
Gross margin22.1%-32.0pp
Operating margin-153.3%+67.8pp
Net margin-143.6%+80.2pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-36.6%+11.9pp
Debt / equity0.2×+0.1×
Current ratio2.4×-1.8×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept mrna:RevenueFromGrantsMaximumAward.

The official record: Moderna’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Moderna's grant revenue — award amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Moderna's grant revenue — award amount?
Moderna (MRNA) reported grant revenue — award amount of $590M in Q1 2025.
What does grant revenue — award amount mean?
This represents the maximum authorized funding amount committed by grantors for specific research programs. It serves as a forward-looking indicator of potential future revenue streams tied to research milestones. Monitoring this helps investors understand the total scope of external financial backing for the company's R&D efforts.